As a result, combining innovative anti‐inflammatory techniques with antithrombotic medications, such as IL‐1 or IL‐6 signaling antagonists, may have a larger benefit in avoiding thrombosis and mortality in COVID‐19 individuals than either therapy alone.271, 272, 273. The gene discussed is IL6; the disease is COVID-19.